Nimodipine Prices, Coupons and Patient Assistance Programs
Nimodipine is a member of the calcium channel blocking agents drug class and is commonly used for Ischemic Stroke, Migraine Prevention, and Subarachnoid Hemorrhage.
The cost for nimodipine oral capsule 30 mg is around $82 for a supply of 30 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This nimodipine price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
|20 (5 x 4 each)||$6.38||$127.63|
|30||$2.73 – $6.22||$81.90 – $186.70|
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Nimodipine Coupons and Rebates
Nimodipine offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Nimodipine
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about nimodipine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- 3 Reviews
- Drug class: calcium channel blocking agents
- FDA Alerts (2)